nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2B6—Thiotepa—sarcoma	0.212	0.47	CbGbCtD
Promethazine—ABCB1—Dactinomycin—sarcoma	0.0522	0.116	CbGbCtD
Promethazine—ABCB1—Mitoxantrone—sarcoma	0.0467	0.104	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—sarcoma	0.0392	0.087	CbGbCtD
Promethazine—ABCB1—Vincristine—sarcoma	0.0322	0.0713	CbGbCtD
Promethazine—ABCB1—Etoposide—sarcoma	0.0295	0.0654	CbGbCtD
Promethazine—ABCB1—Doxorubicin—sarcoma	0.0201	0.0446	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—sarcoma	0.0189	0.042	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—sarcoma	0.01	0.0883	CbGeAlD
Promethazine—HRH4—hematopoietic system—sarcoma	0.00582	0.0513	CbGeAlD
Promethazine—HTR2A—pulmonary artery—sarcoma	0.00504	0.0444	CbGeAlD
Promethazine—HRH4—bone marrow—sarcoma	0.00373	0.0329	CbGeAlD
Promethazine—HTR2A—hindlimb—sarcoma	0.00305	0.0268	CbGeAlD
Promethazine—CALM3—mammary gland—sarcoma	0.00267	0.0235	CbGeAlD
Promethazine—HTR2A—appendage—sarcoma	0.00261	0.023	CbGeAlD
Promethazine—CALM2—endothelium—sarcoma	0.0026	0.0229	CbGeAlD
Promethazine—CALM1—endothelium—sarcoma	0.00259	0.0228	CbGeAlD
Promethazine—Dermatitis contact—Thiotepa—sarcoma	0.00213	0.0114	CcSEcCtD
Promethazine—CALM1—mammary gland—sarcoma	0.00209	0.0184	CbGeAlD
Promethazine—CHRM5—skin of body—sarcoma	0.00203	0.0179	CbGeAlD
Promethazine—Aplastic anaemia—Dactinomycin—sarcoma	0.00201	0.0107	CcSEcCtD
Promethazine—Necrosis—Etoposide—sarcoma	0.00197	0.0106	CcSEcCtD
Promethazine—CALM3—myometrium—sarcoma	0.00189	0.0167	CbGeAlD
Promethazine—Apnoea—Etoposide—sarcoma	0.00183	0.00977	CcSEcCtD
Promethazine—Phlebitis—Dactinomycin—sarcoma	0.0018	0.00964	CcSEcCtD
Promethazine—Sensory loss—Etoposide—sarcoma	0.00179	0.00956	CcSEcCtD
Promethazine—Extravasation—Etoposide—sarcoma	0.00178	0.00949	CcSEcCtD
Promethazine—Coma—Vincristine—sarcoma	0.00175	0.00934	CcSEcCtD
Promethazine—CALM3—seminal vesicle—sarcoma	0.00171	0.0151	CbGeAlD
Promethazine—CHRM4—testis—sarcoma	0.00164	0.0144	CbGeAlD
Promethazine—Venous thrombosis—Epirubicin—sarcoma	0.00161	0.0086	CcSEcCtD
Promethazine—HTR2A—endothelium—sarcoma	0.00158	0.0139	CbGeAlD
Promethazine—Phlebitis—Mitoxantrone—sarcoma	0.00157	0.00839	CcSEcCtD
Promethazine—CYP2C9—mammary gland—sarcoma	0.00154	0.0136	CbGeAlD
Promethazine—Swelling—Mitoxantrone—sarcoma	0.00153	0.00819	CcSEcCtD
Promethazine—Urinary retention—Thiotepa—sarcoma	0.00149	0.00796	CcSEcCtD
Promethazine—Venous thrombosis—Doxorubicin—sarcoma	0.00149	0.00796	CcSEcCtD
Promethazine—CALM2—myometrium—sarcoma	0.00149	0.0131	CbGeAlD
Promethazine—CALM1—myometrium—sarcoma	0.00148	0.013	CbGeAlD
Promethazine—CALM3—smooth muscle tissue—sarcoma	0.00143	0.0126	CbGeAlD
Promethazine—CALM2—embryo—sarcoma	0.00143	0.0126	CbGeAlD
Promethazine—CALM1—embryo—sarcoma	0.00142	0.0126	CbGeAlD
Promethazine—CALM2—seminal vesicle—sarcoma	0.00134	0.0118	CbGeAlD
Promethazine—Urinary retention—Vincristine—sarcoma	0.00132	0.00706	CcSEcCtD
Promethazine—Phlebitis—Etoposide—sarcoma	0.00131	0.00698	CcSEcCtD
Promethazine—CALM2—hematopoietic system—sarcoma	0.00128	0.0113	CbGeAlD
Promethazine—Swelling—Etoposide—sarcoma	0.00127	0.00681	CcSEcCtD
Promethazine—CALM1—hematopoietic system—sarcoma	0.00127	0.0112	CbGeAlD
Promethazine—Paralysis—Epirubicin—sarcoma	0.00125	0.00668	CcSEcCtD
Promethazine—CALM3—cardiac atrium—sarcoma	0.00123	0.0109	CbGeAlD
Promethazine—CALM2—connective tissue—sarcoma	0.00123	0.0108	CbGeAlD
Promethazine—CALM3—uterus—sarcoma	0.00123	0.0108	CbGeAlD
Promethazine—CALM1—connective tissue—sarcoma	0.00122	0.0108	CbGeAlD
Promethazine—ADRA1A—hematopoietic system—sarcoma	0.0012	0.0106	CbGeAlD
Promethazine—Jaundice—Thiotepa—sarcoma	0.00118	0.00629	CcSEcCtD
Promethazine—Paralysis—Doxorubicin—sarcoma	0.00116	0.00618	CcSEcCtD
Promethazine—CHRM3—smooth muscle tissue—sarcoma	0.00115	0.0101	CbGeAlD
Promethazine—Agranulocytosis—Thiotepa—sarcoma	0.00113	0.00602	CcSEcCtD
Promethazine—CALM2—smooth muscle tissue—sarcoma	0.00112	0.00991	CbGeAlD
Promethazine—CALM1—smooth muscle tissue—sarcoma	0.00112	0.00987	CbGeAlD
Promethazine—Agranulocytosis—Dactinomycin—sarcoma	0.00112	0.00597	CcSEcCtD
Promethazine—CALM2—skin of body—sarcoma	0.00111	0.00979	CbGeAlD
Promethazine—Necrosis—Epirubicin—sarcoma	0.00111	0.00591	CcSEcCtD
Promethazine—CALM1—skin of body—sarcoma	0.00111	0.00974	CbGeAlD
Promethazine—Abscess—Epirubicin—sarcoma	0.0011	0.00587	CcSEcCtD
Promethazine—Photosensitivity reaction—Vincristine—sarcoma	0.0011	0.00585	CcSEcCtD
Promethazine—HRH1—myometrium—sarcoma	0.00108	0.00952	CbGeAlD
Promethazine—Hallucination—Thiotepa—sarcoma	0.00108	0.00576	CcSEcCtD
Promethazine—CALM3—tendon—sarcoma	0.00108	0.00949	CbGeAlD
Promethazine—Depression—Vincristine—sarcoma	0.00107	0.0057	CcSEcCtD
Promethazine—CALM3—bone marrow—sarcoma	0.00104	0.00919	CbGeAlD
Promethazine—Drowsiness—Mitoxantrone—sarcoma	0.00104	0.00557	CcSEcCtD
Promethazine—Necrosis—Doxorubicin—sarcoma	0.00102	0.00547	CcSEcCtD
Promethazine—Jaundice—Mitoxantrone—sarcoma	0.00102	0.00543	CcSEcCtD
Promethazine—Abscess—Doxorubicin—sarcoma	0.00102	0.00543	CcSEcCtD
Promethazine—Tinnitus—Thiotepa—sarcoma	0.00101	0.0054	CcSEcCtD
Promethazine—Delirium—Epirubicin—sarcoma	0.00101	0.0054	CcSEcCtD
Promethazine—Extravasation—Epirubicin—sarcoma	0.000995	0.00532	CcSEcCtD
Promethazine—Jaundice cholestatic—Epirubicin—sarcoma	0.000988	0.00528	CcSEcCtD
Promethazine—Agranulocytosis—Mitoxantrone—sarcoma	0.000972	0.0052	CcSEcCtD
Promethazine—CALM2—cardiac atrium—sarcoma	0.00097	0.00855	CbGeAlD
Promethazine—Arrhythmia—Thiotepa—sarcoma	0.000968	0.00517	CcSEcCtD
Promethazine—CALM1—cardiac atrium—sarcoma	0.000965	0.00851	CbGeAlD
Promethazine—CALM2—uterus—sarcoma	0.000965	0.0085	CbGeAlD
Promethazine—CALM1—uterus—sarcoma	0.00096	0.00846	CbGeAlD
Promethazine—Hallucination—Vincristine—sarcoma	0.000956	0.00511	CcSEcCtD
Promethazine—Bradycardia—Mitoxantrone—sarcoma	0.000952	0.00509	CcSEcCtD
Promethazine—CYP2B6—hematopoietic system—sarcoma	0.000949	0.00837	CbGeAlD
Promethazine—Erythema—Thiotepa—sarcoma	0.000943	0.00504	CcSEcCtD
Promethazine—CYP2C9—hematopoietic system—sarcoma	0.00094	0.00829	CbGeAlD
Promethazine—Erythema—Dactinomycin—sarcoma	0.000936	0.005	CcSEcCtD
Promethazine—Delirium—Doxorubicin—sarcoma	0.000934	0.00499	CcSEcCtD
Promethazine—HRH1—hematopoietic system—sarcoma	0.000927	0.00817	CbGeAlD
Promethazine—Tension—Thiotepa—sarcoma	0.000925	0.00495	CcSEcCtD
Promethazine—Dyskinesia—Epirubicin—sarcoma	0.000924	0.00494	CcSEcCtD
Promethazine—Extravasation—Doxorubicin—sarcoma	0.000921	0.00492	CcSEcCtD
Promethazine—Nervousness—Thiotepa—sarcoma	0.000916	0.00489	CcSEcCtD
Promethazine—Jaundice cholestatic—Doxorubicin—sarcoma	0.000915	0.00489	CcSEcCtD
Promethazine—CALM2—lymphoid tissue—sarcoma	0.000899	0.00793	CbGeAlD
Promethazine—CALM1—lymphoid tissue—sarcoma	0.000895	0.00789	CbGeAlD
Promethazine—HRH1—connective tissue—sarcoma	0.000893	0.00787	CbGeAlD
Promethazine—CALM3—testis—sarcoma	0.000891	0.00786	CbGeAlD
Promethazine—Vision blurred—Thiotepa—sarcoma	0.000889	0.00475	CcSEcCtD
Promethazine—Coordination abnormal—Epirubicin—sarcoma	0.000884	0.00473	CcSEcCtD
Promethazine—HTR2A—embryo—sarcoma	0.000867	0.00765	CbGeAlD
Promethazine—Agitation—Thiotepa—sarcoma	0.000866	0.00463	CcSEcCtD
Promethazine—Injection site reaction—Epirubicin—sarcoma	0.000863	0.00461	CcSEcCtD
Promethazine—Dermatitis contact—Epirubicin—sarcoma	0.000858	0.00459	CcSEcCtD
Promethazine—Dyskinesia—Doxorubicin—sarcoma	0.000855	0.00457	CcSEcCtD
Promethazine—CALM2—tendon—sarcoma	0.000845	0.00745	CbGeAlD
Promethazine—Jaundice—Etoposide—sarcoma	0.000845	0.00452	CcSEcCtD
Promethazine—Leukopenia—Thiotepa—sarcoma	0.000844	0.00451	CcSEcCtD
Promethazine—ADRA1A—lymphoid tissue—sarcoma	0.000843	0.00743	CbGeAlD
Promethazine—CALM3—liver—sarcoma	0.000842	0.00743	CbGeAlD
Promethazine—CALM1—tendon—sarcoma	0.000841	0.00742	CbGeAlD
Promethazine—Leukopenia—Dactinomycin—sarcoma	0.000838	0.00448	CcSEcCtD
Promethazine—Arrhythmia—Mitoxantrone—sarcoma	0.000836	0.00447	CcSEcCtD
Promethazine—CYP2B6—skin of body—sarcoma	0.000825	0.00728	CbGeAlD
Promethazine—CALM2—bone marrow—sarcoma	0.000819	0.00722	CbGeAlD
Promethazine—Coordination abnormal—Doxorubicin—sarcoma	0.000818	0.00437	CcSEcCtD
Promethazine—Convulsion—Thiotepa—sarcoma	0.000817	0.00437	CcSEcCtD
Promethazine—HRH1—smooth muscle tissue—sarcoma	0.000817	0.0072	CbGeAlD
Promethazine—Aplastic anaemia—Epirubicin—sarcoma	0.000815	0.00436	CcSEcCtD
Promethazine—CALM1—bone marrow—sarcoma	0.000815	0.00718	CbGeAlD
Promethazine—Erythema—Mitoxantrone—sarcoma	0.000814	0.00435	CcSEcCtD
Promethazine—Agranulocytosis—Etoposide—sarcoma	0.000809	0.00432	CcSEcCtD
Promethazine—Anxiety—Thiotepa—sarcoma	0.0008	0.00428	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—sarcoma	0.000799	0.00427	CcSEcCtD
Promethazine—Dermatitis contact—Doxorubicin—sarcoma	0.000794	0.00424	CcSEcCtD
Promethazine—Coma—Epirubicin—sarcoma	0.000794	0.00424	CcSEcCtD
Promethazine—Confusional state—Thiotepa—sarcoma	0.000776	0.00415	CcSEcCtD
Promethazine—HTR2A—hematopoietic system—sarcoma	0.000774	0.00683	CbGeAlD
Promethazine—Agitation—Vincristine—sarcoma	0.000768	0.00411	CcSEcCtD
Promethazine—Vision blurred—Mitoxantrone—sarcoma	0.000767	0.0041	CcSEcCtD
Promethazine—Oedema—Dactinomycin—sarcoma	0.000764	0.00408	CcSEcCtD
Promethazine—Aplastic anaemia—Doxorubicin—sarcoma	0.000754	0.00403	CcSEcCtD
Promethazine—Thrombocytopenia—Thiotepa—sarcoma	0.000753	0.00403	CcSEcCtD
Promethazine—Tachycardia—Thiotepa—sarcoma	0.000751	0.00401	CcSEcCtD
Promethazine—Leukopenia—Vincristine—sarcoma	0.000748	0.004	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—sarcoma	0.000748	0.004	CcSEcCtD
Promethazine—HTR2A—connective tissue—sarcoma	0.000746	0.00657	CbGeAlD
Promethazine—Coma—Doxorubicin—sarcoma	0.000734	0.00392	CcSEcCtD
Promethazine—Phlebitis—Epirubicin—sarcoma	0.000732	0.00391	CcSEcCtD
Promethazine—Leukopenia—Mitoxantrone—sarcoma	0.000729	0.0039	CcSEcCtD
Promethazine—Thrombophlebitis—Epirubicin—sarcoma	0.000728	0.00389	CcSEcCtD
Promethazine—Convulsion—Vincristine—sarcoma	0.000724	0.00387	CcSEcCtD
Promethazine—Photosensitivity—Epirubicin—sarcoma	0.000718	0.00384	CcSEcCtD
Promethazine—CHRM3—testis—sarcoma	0.000715	0.0063	CbGeAlD
Promethazine—Convulsion—Mitoxantrone—sarcoma	0.000705	0.00377	CcSEcCtD
Promethazine—CYP2D6—hematopoietic system—sarcoma	0.000705	0.00622	CbGeAlD
Promethazine—CALM2—testis—sarcoma	0.0007	0.00617	CbGeAlD
Promethazine—CALM1—testis—sarcoma	0.000697	0.00614	CbGeAlD
Promethazine—Anxiety—Mitoxantrone—sarcoma	0.000691	0.00369	CcSEcCtD
Promethazine—Somnolence—Thiotepa—sarcoma	0.000684	0.00366	CcSEcCtD
Promethazine—Anaphylactic shock—Vincristine—sarcoma	0.000682	0.00365	CcSEcCtD
Promethazine—Oedema—Vincristine—sarcoma	0.000682	0.00365	CcSEcCtD
Promethazine—HTR2A—smooth muscle tissue—sarcoma	0.000682	0.00601	CbGeAlD
Promethazine—Dyspepsia—Thiotepa—sarcoma	0.000677	0.00362	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—sarcoma	0.000677	0.00362	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—sarcoma	0.000674	0.0036	CcSEcCtD
Promethazine—Confusional state—Mitoxantrone—sarcoma	0.00067	0.00358	CcSEcCtD
Promethazine—Decreased appetite—Thiotepa—sarcoma	0.000669	0.00358	CcSEcCtD
Promethazine—CYP2B6—lymphoid tissue—sarcoma	0.000668	0.00589	CbGeAlD
Promethazine—Thrombocytopenia—Vincristine—sarcoma	0.000668	0.00357	CcSEcCtD
Promethazine—Oedema—Mitoxantrone—sarcoma	0.000665	0.00355	CcSEcCtD
Promethazine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000665	0.00355	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—sarcoma	0.000664	0.00355	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—sarcoma	0.000664	0.00355	CcSEcCtD
Promethazine—Fatigue—Thiotepa—sarcoma	0.000663	0.00355	CcSEcCtD
Promethazine—CALM2—liver—sarcoma	0.000662	0.00583	CbGeAlD
Promethazine—CALM1—liver—sarcoma	0.000659	0.00581	CbGeAlD
Promethazine—Fatigue—Dactinomycin—sarcoma	0.000658	0.00352	CcSEcCtD
Promethazine—Constipation—Thiotepa—sarcoma	0.000658	0.00352	CcSEcCtD
Promethazine—Pain—Thiotepa—sarcoma	0.000658	0.00352	CcSEcCtD
Promethazine—Shock—Mitoxantrone—sarcoma	0.000654	0.00349	CcSEcCtD
Promethazine—Pain—Dactinomycin—sarcoma	0.000653	0.00349	CcSEcCtD
Promethazine—Muscle spasms—Etoposide—sarcoma	0.000651	0.00348	CcSEcCtD
Promethazine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000651	0.00348	CcSEcCtD
Promethazine—Tachycardia—Mitoxantrone—sarcoma	0.000649	0.00347	CcSEcCtD
Promethazine—CALM3—lymph node—sarcoma	0.000646	0.00569	CbGeAlD
Promethazine—DRD2—testis—sarcoma	0.000643	0.00567	CbGeAlD
Promethazine—Hypotension—Vincristine—sarcoma	0.000638	0.00341	CcSEcCtD
Promethazine—Feeling abnormal—Thiotepa—sarcoma	0.000634	0.00339	CcSEcCtD
Promethazine—Diplopia—Epirubicin—sarcoma	0.00063	0.00337	CcSEcCtD
Promethazine—Feeling abnormal—Dactinomycin—sarcoma	0.000629	0.00336	CcSEcCtD
Promethazine—Hypotension—Mitoxantrone—sarcoma	0.000621	0.00332	CcSEcCtD
Promethazine—ADRA1A—liver—sarcoma	0.000621	0.00547	CbGeAlD
Promethazine—Insomnia—Vincristine—sarcoma	0.000617	0.0033	CcSEcCtD
Promethazine—HRH1—tendon—sarcoma	0.000614	0.00541	CbGeAlD
Promethazine—Leukopenia—Etoposide—sarcoma	0.000606	0.00324	CcSEcCtD
Promethazine—Loss of consciousness—Etoposide—sarcoma	0.000595	0.00318	CcSEcCtD
Promethazine—Decreased appetite—Vincristine—sarcoma	0.000593	0.00317	CcSEcCtD
Promethazine—ABCB1—myometrium—sarcoma	0.000591	0.00521	CbGeAlD
Promethazine—Somnolence—Mitoxantrone—sarcoma	0.000591	0.00316	CcSEcCtD
Promethazine—Fatigue—Vincristine—sarcoma	0.000588	0.00314	CcSEcCtD
Promethazine—Convulsion—Etoposide—sarcoma	0.000587	0.00314	CcSEcCtD
Promethazine—Dyspepsia—Mitoxantrone—sarcoma	0.000585	0.00313	CcSEcCtD
Promethazine—Constipation—Vincristine—sarcoma	0.000584	0.00312	CcSEcCtD
Promethazine—Pain—Vincristine—sarcoma	0.000584	0.00312	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—sarcoma	0.000583	0.00312	CcSEcCtD
Promethazine—Decreased appetite—Mitoxantrone—sarcoma	0.000578	0.00309	CcSEcCtD
Promethazine—Fatigue—Mitoxantrone—sarcoma	0.000573	0.00306	CcSEcCtD
Promethazine—ABCB1—embryo—sarcoma	0.000568	0.00501	CbGeAlD
Promethazine—Constipation—Mitoxantrone—sarcoma	0.000568	0.00304	CcSEcCtD
Promethazine—Pain—Mitoxantrone—sarcoma	0.000568	0.00304	CcSEcCtD
Promethazine—Confusional state—Etoposide—sarcoma	0.000557	0.00298	CcSEcCtD
Promethazine—Anaphylactic shock—Etoposide—sarcoma	0.000553	0.00295	CcSEcCtD
Promethazine—Asthenia—Thiotepa—sarcoma	0.000552	0.00295	CcSEcCtD
Promethazine—Asthenia—Dactinomycin—sarcoma	0.000548	0.00293	CcSEcCtD
Promethazine—Feeling abnormal—Mitoxantrone—sarcoma	0.000548	0.00293	CcSEcCtD
Promethazine—Asthma—Epirubicin—sarcoma	0.000545	0.00291	CcSEcCtD
Promethazine—Pruritus—Thiotepa—sarcoma	0.000544	0.00291	CcSEcCtD
Promethazine—Thrombocytopenia—Etoposide—sarcoma	0.000541	0.00289	CcSEcCtD
Promethazine—Tachycardia—Etoposide—sarcoma	0.000539	0.00288	CcSEcCtD
Promethazine—ABCB1—seminal vesicle—sarcoma	0.000534	0.00471	CbGeAlD
Promethazine—Diarrhoea—Thiotepa—sarcoma	0.000527	0.00281	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—sarcoma	0.000523	0.00279	CcSEcCtD
Promethazine—CYP2B6—testis—sarcoma	0.00052	0.00459	CbGeAlD
Promethazine—Hypotension—Etoposide—sarcoma	0.000517	0.00276	CcSEcCtD
Promethazine—HTR2A—tendon—sarcoma	0.000512	0.00452	CbGeAlD
Promethazine—Dizziness—Thiotepa—sarcoma	0.000509	0.00272	CcSEcCtD
Promethazine—HRH1—testis—sarcoma	0.000508	0.00448	CbGeAlD
Promethazine—ABCB1—hematopoietic system—sarcoma	0.000507	0.00447	CbGeAlD
Promethazine—CALM2—lymph node—sarcoma	0.000507	0.00447	CbGeAlD
Promethazine—CALM1—lymph node—sarcoma	0.000505	0.00445	CbGeAlD
Promethazine—Asthma—Doxorubicin—sarcoma	0.000504	0.00269	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—sarcoma	0.000497	0.00266	CcSEcCtD
Promethazine—CYP2B6—liver—sarcoma	0.000492	0.00434	CbGeAlD
Promethazine—Somnolence—Etoposide—sarcoma	0.000491	0.00263	CcSEcCtD
Promethazine—Asthenia—Vincristine—sarcoma	0.00049	0.00262	CcSEcCtD
Promethazine—CYP2C9—liver—sarcoma	0.000487	0.00429	CbGeAlD
Promethazine—Drowsiness—Epirubicin—sarcoma	0.000486	0.0026	CcSEcCtD
Promethazine—Rash—Thiotepa—sarcoma	0.000485	0.00259	CcSEcCtD
Promethazine—Dermatitis—Thiotepa—sarcoma	0.000485	0.00259	CcSEcCtD
Promethazine—Headache—Thiotepa—sarcoma	0.000482	0.00258	CcSEcCtD
Promethazine—Rash—Dactinomycin—sarcoma	0.000482	0.00257	CcSEcCtD
Promethazine—Decreased appetite—Etoposide—sarcoma	0.000481	0.00257	CcSEcCtD
Promethazine—Asthenia—Mitoxantrone—sarcoma	0.000477	0.00255	CcSEcCtD
Promethazine—Fatigue—Etoposide—sarcoma	0.000477	0.00255	CcSEcCtD
Promethazine—Jaundice—Epirubicin—sarcoma	0.000474	0.00253	CcSEcCtD
Promethazine—Constipation—Etoposide—sarcoma	0.000473	0.00253	CcSEcCtD
Promethazine—Pain—Etoposide—sarcoma	0.000473	0.00253	CcSEcCtD
Promethazine—Diarrhoea—Vincristine—sarcoma	0.000467	0.0025	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00046	0.00246	CcSEcCtD
Promethazine—Feeling abnormal—Etoposide—sarcoma	0.000456	0.00243	CcSEcCtD
Promethazine—Diarrhoea—Mitoxantrone—sarcoma	0.000455	0.00243	CcSEcCtD
Promethazine—Agranulocytosis—Epirubicin—sarcoma	0.000453	0.00242	CcSEcCtD
Promethazine—Dizziness—Vincristine—sarcoma	0.000451	0.00241	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—sarcoma	0.00045	0.0024	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—sarcoma	0.000444	0.00237	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—sarcoma	0.000438	0.00234	CcSEcCtD
Promethazine—Rash—Vincristine—sarcoma	0.00043	0.0023	CcSEcCtD
Promethazine—Dermatitis—Vincristine—sarcoma	0.00043	0.0023	CcSEcCtD
Promethazine—Headache—Vincristine—sarcoma	0.000427	0.00228	CcSEcCtD
Promethazine—HTR2A—testis—sarcoma	0.000424	0.00374	CbGeAlD
Promethazine—Agranulocytosis—Doxorubicin—sarcoma	0.000419	0.00224	CcSEcCtD
Promethazine—Rash—Mitoxantrone—sarcoma	0.000419	0.00224	CcSEcCtD
Promethazine—Dermatitis—Mitoxantrone—sarcoma	0.000419	0.00224	CcSEcCtD
Promethazine—Headache—Mitoxantrone—sarcoma	0.000416	0.00223	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—sarcoma	0.000411	0.0022	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—sarcoma	0.000407	0.00217	CcSEcCtD
Promethazine—HTR2A—liver—sarcoma	0.000401	0.00354	CbGeAlD
Promethazine—Asthenia—Etoposide—sarcoma	0.000397	0.00212	CcSEcCtD
Promethazine—Pruritus—Etoposide—sarcoma	0.000391	0.00209	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—sarcoma	0.00039	0.00208	CcSEcCtD
Promethazine—CYP2D6—testis—sarcoma	0.000387	0.00341	CbGeAlD
Promethazine—ABCB1—uterus—sarcoma	0.000383	0.00338	CbGeAlD
Promethazine—Erythema—Epirubicin—sarcoma	0.00038	0.00203	CcSEcCtD
Promethazine—Diarrhoea—Etoposide—sarcoma	0.000378	0.00202	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—sarcoma	0.000376	0.00201	CcSEcCtD
Promethazine—Tension—Epirubicin—sarcoma	0.000373	0.00199	CcSEcCtD
Promethazine—Nervousness—Epirubicin—sarcoma	0.000369	0.00197	CcSEcCtD
Promethazine—HRH1—lymph node—sarcoma	0.000368	0.00325	CbGeAlD
Promethazine—Dizziness—Etoposide—sarcoma	0.000366	0.00195	CcSEcCtD
Promethazine—CYP2D6—liver—sarcoma	0.000365	0.00322	CbGeAlD
Promethazine—Muscle spasms—Epirubicin—sarcoma	0.000365	0.00195	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—sarcoma	0.00036	0.00193	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—sarcoma	0.000358	0.00191	CcSEcCtD
Promethazine—ABCB1—lymphoid tissue—sarcoma	0.000357	0.00315	CbGeAlD
Promethazine—Erythema—Doxorubicin—sarcoma	0.000351	0.00188	CcSEcCtD
Promethazine—Agitation—Epirubicin—sarcoma	0.000349	0.00186	CcSEcCtD
Promethazine—Rash—Etoposide—sarcoma	0.000349	0.00186	CcSEcCtD
Promethazine—Dermatitis—Etoposide—sarcoma	0.000348	0.00186	CcSEcCtD
Promethazine—Headache—Etoposide—sarcoma	0.000346	0.00185	CcSEcCtD
Promethazine—Tension—Doxorubicin—sarcoma	0.000345	0.00184	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—sarcoma	0.000341	0.00182	CcSEcCtD
Promethazine—Syncope—Epirubicin—sarcoma	0.00034	0.00182	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—sarcoma	0.00034	0.00182	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—sarcoma	0.000338	0.00181	CcSEcCtD
Promethazine—Palpitations—Epirubicin—sarcoma	0.000336	0.00179	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—sarcoma	0.000334	0.00178	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—sarcoma	0.000331	0.00177	CcSEcCtD
Promethazine—Convulsion—Epirubicin—sarcoma	0.000329	0.00176	CcSEcCtD
Promethazine—ABCB1—bone marrow—sarcoma	0.000325	0.00287	CbGeAlD
Promethazine—Agitation—Doxorubicin—sarcoma	0.000323	0.00173	CcSEcCtD
Promethazine—Anxiety—Epirubicin—sarcoma	0.000322	0.00172	CcSEcCtD
Promethazine—Dry mouth—Epirubicin—sarcoma	0.000316	0.00169	CcSEcCtD
Promethazine—Syncope—Doxorubicin—sarcoma	0.000315	0.00168	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—sarcoma	0.000314	0.00168	CcSEcCtD
Promethazine—Confusional state—Epirubicin—sarcoma	0.000312	0.00167	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—sarcoma	0.00031	0.00166	CcSEcCtD
Promethazine—Oedema—Epirubicin—sarcoma	0.00031	0.00166	CcSEcCtD
Promethazine—Anaphylactic shock—Epirubicin—sarcoma	0.00031	0.00166	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—sarcoma	0.000309	0.00165	CcSEcCtD
Promethazine—Shock—Epirubicin—sarcoma	0.000305	0.00163	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—sarcoma	0.000304	0.00163	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—sarcoma	0.000303	0.00162	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—sarcoma	0.000302	0.00162	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—sarcoma	0.000298	0.00159	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—sarcoma	0.000292	0.00156	CcSEcCtD
Promethazine—Hypotension—Epirubicin—sarcoma	0.00029	0.00155	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—sarcoma	0.000289	0.00155	CcSEcCtD
Promethazine—Oedema—Doxorubicin—sarcoma	0.000287	0.00153	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—sarcoma	0.000287	0.00153	CcSEcCtD
Promethazine—Shock—Doxorubicin—sarcoma	0.000282	0.00151	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—sarcoma	0.000281	0.0015	CcSEcCtD
Promethazine—Insomnia—Epirubicin—sarcoma	0.00028	0.0015	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—sarcoma	0.00028	0.0015	CcSEcCtD
Promethazine—ABCB1—testis—sarcoma	0.000278	0.00245	CbGeAlD
Promethazine—Somnolence—Epirubicin—sarcoma	0.000275	0.00147	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—sarcoma	0.000273	0.00146	CcSEcCtD
Promethazine—Decreased appetite—Epirubicin—sarcoma	0.000269	0.00144	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—sarcoma	0.000268	0.00143	CcSEcCtD
Promethazine—Fatigue—Epirubicin—sarcoma	0.000267	0.00143	CcSEcCtD
Promethazine—Pain—Epirubicin—sarcoma	0.000265	0.00142	CcSEcCtD
Promethazine—Constipation—Epirubicin—sarcoma	0.000265	0.00142	CcSEcCtD
Promethazine—ABCB1—liver—sarcoma	0.000263	0.00232	CbGeAlD
Promethazine—Insomnia—Doxorubicin—sarcoma	0.000259	0.00139	CcSEcCtD
Promethazine—Feeling abnormal—Epirubicin—sarcoma	0.000255	0.00136	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—sarcoma	0.000255	0.00136	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—sarcoma	0.000252	0.00135	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—sarcoma	0.000249	0.00133	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—sarcoma	0.000247	0.00132	CcSEcCtD
Promethazine—Constipation—Doxorubicin—sarcoma	0.000245	0.00131	CcSEcCtD
Promethazine—Pain—Doxorubicin—sarcoma	0.000245	0.00131	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—sarcoma	0.000236	0.00126	CcSEcCtD
Promethazine—Asthenia—Epirubicin—sarcoma	0.000222	0.00119	CcSEcCtD
Promethazine—Pruritus—Epirubicin—sarcoma	0.000219	0.00117	CcSEcCtD
Promethazine—Diarrhoea—Epirubicin—sarcoma	0.000212	0.00113	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—sarcoma	0.000206	0.0011	CcSEcCtD
Promethazine—Dizziness—Epirubicin—sarcoma	0.000205	0.0011	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—sarcoma	0.000203	0.00108	CcSEcCtD
Promethazine—ABCB1—lymph node—sarcoma	0.000202	0.00178	CbGeAlD
Promethazine—Diarrhoea—Doxorubicin—sarcoma	0.000196	0.00105	CcSEcCtD
Promethazine—Rash—Epirubicin—sarcoma	0.000195	0.00104	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—sarcoma	0.000195	0.00104	CcSEcCtD
Promethazine—Headache—Epirubicin—sarcoma	0.000194	0.00104	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—sarcoma	0.00019	0.00101	CcSEcCtD
Promethazine—Rash—Doxorubicin—sarcoma	0.000181	0.000966	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—sarcoma	0.000181	0.000965	CcSEcCtD
Promethazine—Headache—Doxorubicin—sarcoma	0.00018	0.00096	CcSEcCtD
Promethazine—CALM2—Signaling by GPCR—IL2—sarcoma	2.02e-05	8.12e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL2—sarcoma	2.02e-05	8.12e-05	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—HRAS—sarcoma	2.01e-05	8.09e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CREB1—sarcoma	2.01e-05	8.08e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CREB1—sarcoma	2e-05	8.06e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CREB1—sarcoma	2e-05	8.04e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CREB1—sarcoma	1.99e-05	8.01e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CREB1—sarcoma	1.97e-05	7.93e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MDM2—sarcoma	1.97e-05	7.93e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CREB1—sarcoma	1.97e-05	7.91e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—EGFR—sarcoma	1.95e-05	7.86e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—HRAS—sarcoma	1.94e-05	7.82e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—HRAS—sarcoma	1.94e-05	7.82e-05	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—HRAS—sarcoma	1.93e-05	7.77e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—EGFR—sarcoma	1.92e-05	7.73e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—EGFR—sarcoma	1.92e-05	7.72e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—EGFR—sarcoma	1.91e-05	7.69e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—SRC—sarcoma	1.91e-05	7.69e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL2—sarcoma	1.91e-05	7.67e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—EGFR—sarcoma	1.91e-05	7.67e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MDM2—sarcoma	1.91e-05	7.67e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MDM2—sarcoma	1.91e-05	7.67e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KDR—sarcoma	1.9e-05	7.65e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—EGFR—sarcoma	1.89e-05	7.59e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—EGFR—sarcoma	1.88e-05	7.57e-05	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—HRAS—sarcoma	1.87e-05	7.51e-05	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—HRAS—sarcoma	1.87e-05	7.51e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—VEGFA—sarcoma	1.86e-05	7.49e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—JUN—sarcoma	1.85e-05	7.46e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—KRAS—sarcoma	1.85e-05	7.43e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL2—sarcoma	1.84e-05	7.42e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL2—sarcoma	1.84e-05	7.42e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—CTNNB1—sarcoma	1.84e-05	7.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KDR—sarcoma	1.84e-05	7.4e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KDR—sarcoma	1.84e-05	7.4e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—NRAS—sarcoma	1.84e-05	7.4e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—SRC—sarcoma	1.83e-05	7.36e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—KRAS—sarcoma	1.82e-05	7.31e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—KRAS—sarcoma	1.81e-05	7.29e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—KRAS—sarcoma	1.81e-05	7.27e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—KRAS—sarcoma	1.8e-05	7.24e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—JUN—sarcoma	1.79e-05	7.22e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—JUN—sarcoma	1.79e-05	7.22e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—KRAS—sarcoma	1.78e-05	7.17e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—VEGFA—sarcoma	1.78e-05	7.17e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—CTNNB1—sarcoma	1.78e-05	7.16e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—CTNNB1—sarcoma	1.78e-05	7.16e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	1.78e-05	7.15e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—NRAS—sarcoma	1.76e-05	7.08e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KIT—sarcoma	1.75e-05	7.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—NRAS—sarcoma	1.75e-05	7.05e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MYC—sarcoma	1.71e-05	6.89e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—CTNNB1—sarcoma	1.7e-05	6.84e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KIT—sarcoma	1.69e-05	6.82e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KIT—sarcoma	1.69e-05	6.82e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—NRAS—sarcoma	1.69e-05	6.82e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—NRAS—sarcoma	1.69e-05	6.82e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MDM2—sarcoma	1.69e-05	6.8e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EGFR—sarcoma	1.68e-05	6.74e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CREB1—sarcoma	1.67e-05	6.71e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—SRC—sarcoma	1.66e-05	6.69e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MDM2—sarcoma	1.66e-05	6.69e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MDM2—sarcoma	1.66e-05	6.67e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MDM2—sarcoma	1.65e-05	6.65e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MDM2—sarcoma	1.65e-05	6.63e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—CTNNB1—sarcoma	1.64e-05	6.61e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—CTNNB1—sarcoma	1.64e-05	6.61e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MYC—sarcoma	1.64e-05	6.6e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MDM2—sarcoma	1.63e-05	6.56e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MDM2—sarcoma	1.63e-05	6.55e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CREB1—sarcoma	1.61e-05	6.49e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CREB1—sarcoma	1.61e-05	6.49e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—SRC—sarcoma	1.61e-05	6.47e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—SRC—sarcoma	1.61e-05	6.47e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EGFR—sarcoma	1.6e-05	6.45e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—NRAS—sarcoma	1.6e-05	6.44e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—EGFR—sarcoma	1.6e-05	6.42e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KRAS—sarcoma	1.58e-05	6.37e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HRAS—sarcoma	1.57e-05	6.31e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—NRAS—sarcoma	1.55e-05	6.23e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—NRAS—sarcoma	1.55e-05	6.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—EGFR—sarcoma	1.54e-05	6.21e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—EGFR—sarcoma	1.54e-05	6.21e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—HRAS—sarcoma	1.54e-05	6.21e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HRAS—sarcoma	1.54e-05	6.2e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—SRC—sarcoma	1.54e-05	6.18e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HRAS—sarcoma	1.54e-05	6.18e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HRAS—sarcoma	1.53e-05	6.16e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HRAS—sarcoma	1.52e-05	6.1e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KRAS—sarcoma	1.52e-05	6.1e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	1.51e-05	6.08e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL2—sarcoma	1.51e-05	6.07e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—KRAS—sarcoma	1.51e-05	6.07e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—SRC—sarcoma	1.49e-05	5.98e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—SRC—sarcoma	1.49e-05	5.98e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL2—sarcoma	1.49e-05	5.97e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL2—sarcoma	1.48e-05	5.96e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—NRAS—sarcoma	1.48e-05	5.94e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL2—sarcoma	1.48e-05	5.94e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL2—sarcoma	1.47e-05	5.92e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCND1—sarcoma	1.47e-05	5.92e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—JUN—sarcoma	1.47e-05	5.91e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—KRAS—sarcoma	1.46e-05	5.87e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—KRAS—sarcoma	1.46e-05	5.87e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EGFR—sarcoma	1.46e-05	5.87e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL2—sarcoma	1.46e-05	5.87e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.46e-05	5.86e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL2—sarcoma	1.45e-05	5.85e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCND1—sarcoma	1.45e-05	5.82e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—JUN—sarcoma	1.44e-05	5.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCND1—sarcoma	1.44e-05	5.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—JUN—sarcoma	1.44e-05	5.8e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCND1—sarcoma	1.44e-05	5.79e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—JUN—sarcoma	1.44e-05	5.78e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCND1—sarcoma	1.44e-05	5.77e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CTNNB1—sarcoma	1.43e-05	5.77e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—JUN—sarcoma	1.43e-05	5.76e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CTNNB1—sarcoma	1.43e-05	5.75e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—NRAS—sarcoma	1.43e-05	5.75e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—NRAS—sarcoma	1.43e-05	5.75e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CTNNB1—sarcoma	1.43e-05	5.74e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCND1—sarcoma	1.42e-05	5.72e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CTNNB1—sarcoma	1.42e-05	5.72e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—JUN—sarcoma	1.42e-05	5.71e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCND1—sarcoma	1.42e-05	5.7e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—JUN—sarcoma	1.41e-05	5.69e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EGFR—sarcoma	1.41e-05	5.67e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EGFR—sarcoma	1.41e-05	5.67e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CTNNB1—sarcoma	1.41e-05	5.66e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—sarcoma	1.41e-05	5.66e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	1.4e-05	5.65e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MDM2—sarcoma	1.38e-05	5.55e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—KRAS—sarcoma	1.38e-05	5.54e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MYC—sarcoma	1.38e-05	5.54e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—sarcoma	1.35e-05	5.42e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—sarcoma	1.35e-05	5.42e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—sarcoma	1.35e-05	5.41e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MDM2—sarcoma	1.33e-05	5.37e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MDM2—sarcoma	1.33e-05	5.37e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—sarcoma	1.33e-05	5.36e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—sarcoma	1.33e-05	5.36e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—sarcoma	1.33e-05	5.36e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—sarcoma	1.33e-05	5.36e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SRC—sarcoma	1.32e-05	5.3e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—sarcoma	1.3e-05	5.24e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—sarcoma	1.3e-05	5.24e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SRC—sarcoma	1.3e-05	5.21e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SRC—sarcoma	1.29e-05	5.2e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SRC—sarcoma	1.29e-05	5.19e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—sarcoma	1.29e-05	5.18e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SRC—sarcoma	1.28e-05	5.17e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—sarcoma	1.28e-05	5.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—sarcoma	1.28e-05	5.16e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SRC—sarcoma	1.27e-05	5.12e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—sarcoma	1.27e-05	5.12e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SRC—sarcoma	1.27e-05	5.1e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—sarcoma	1.27e-05	5.1e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—sarcoma	1.26e-05	5.08e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—sarcoma	1.26e-05	5.07e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—sarcoma	1.26e-05	5.05e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—sarcoma	1.25e-05	5.03e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—sarcoma	1.25e-05	5.02e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—sarcoma	1.24e-05	5e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—sarcoma	1.24e-05	4.99e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—sarcoma	1.24e-05	4.99e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—sarcoma	1.24e-05	4.99e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—sarcoma	1.24e-05	4.99e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—sarcoma	1.24e-05	4.97e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	1.24e-05	4.97e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—sarcoma	1.23e-05	4.96e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—sarcoma	1.23e-05	4.95e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—sarcoma	1.23e-05	4.95e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—sarcoma	1.22e-05	4.92e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—sarcoma	1.22e-05	4.91e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—sarcoma	1.2e-05	4.83e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—JUN—sarcoma	1.2e-05	4.82e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—sarcoma	1.19e-05	4.8e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—sarcoma	1.19e-05	4.8e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—sarcoma	1.19e-05	4.79e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—sarcoma	1.18e-05	4.75e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—sarcoma	1.17e-05	4.71e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—sarcoma	1.16e-05	4.68e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—sarcoma	1.16e-05	4.68e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—sarcoma	1.16e-05	4.67e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—JUN—sarcoma	1.16e-05	4.67e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—JUN—sarcoma	1.16e-05	4.67e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—sarcoma	1.16e-05	4.66e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—sarcoma	1.15e-05	4.65e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—sarcoma	1.15e-05	4.64e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—sarcoma	1.15e-05	4.63e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—sarcoma	1.15e-05	4.63e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—sarcoma	1.15e-05	4.63e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—sarcoma	1.14e-05	4.59e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—sarcoma	1.14e-05	4.57e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—sarcoma	1.14e-05	4.57e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—sarcoma	1.13e-05	4.56e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—sarcoma	1.13e-05	4.56e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—sarcoma	1.13e-05	4.56e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—sarcoma	1.13e-05	4.54e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—sarcoma	1.13e-05	4.53e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—sarcoma	1.12e-05	4.49e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—sarcoma	1.11e-05	4.47e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—sarcoma	1.09e-05	4.39e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—sarcoma	1.08e-05	4.35e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SRC—sarcoma	1.08e-05	4.33e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—sarcoma	1.07e-05	4.32e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—sarcoma	1.07e-05	4.31e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—sarcoma	1.07e-05	4.29e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—sarcoma	1.06e-05	4.28e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—sarcoma	1.05e-05	4.24e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—sarcoma	1.05e-05	4.23e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—sarcoma	1.05e-05	4.21e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—sarcoma	1.05e-05	4.21e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—sarcoma	1.05e-05	4.21e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SRC—sarcoma	1.04e-05	4.19e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SRC—sarcoma	1.04e-05	4.19e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—sarcoma	1.03e-05	4.16e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—sarcoma	1.01e-05	4.08e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—sarcoma	1.01e-05	4.08e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—sarcoma	1e-05	4.03e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—sarcoma	1e-05	4.03e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—sarcoma	9.69e-06	3.9e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—sarcoma	9.64e-06	3.88e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—sarcoma	9.54e-06	3.84e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—sarcoma	9.52e-06	3.83e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—sarcoma	9.49e-06	3.82e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—sarcoma	9.45e-06	3.8e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—sarcoma	9.43e-06	3.79e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—sarcoma	9.36e-06	3.77e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—sarcoma	9.34e-06	3.76e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—sarcoma	9.32e-06	3.75e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—sarcoma	9.32e-06	3.75e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—sarcoma	9.27e-06	3.73e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—sarcoma	9.12e-06	3.67e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—sarcoma	9.12e-06	3.67e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—sarcoma	9.12e-06	3.67e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—sarcoma	9.1e-06	3.66e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—sarcoma	9.07e-06	3.65e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—sarcoma	9.04e-06	3.64e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—sarcoma	8.95e-06	3.6e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—sarcoma	8.93e-06	3.59e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—sarcoma	8.91e-06	3.58e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—sarcoma	8.62e-06	3.47e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—sarcoma	8.62e-06	3.47e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—sarcoma	7.92e-06	3.18e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—sarcoma	7.66e-06	3.08e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—sarcoma	7.66e-06	3.08e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—sarcoma	7.57e-06	3.05e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—sarcoma	7.32e-06	2.95e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—sarcoma	7.32e-06	2.95e-05	CbGpPWpGaD
